X
19
Sandoz B2B, based in Switzerland, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
They are recognized for A global leader in antibiotics.
One of their notable products is DIGOXIN, with a corresponding application number 2048264 and regulatory information .
proudly manufactured in the
Sandoz B2B's DIGOXIN INJECTION C.S.D. LIQUID, medication with 0.5MG/2ML of DIGOXIN.